-
"Innovative Drug One Brother" Outbreak This month, 10 Class 1 New Drugs Intensively Strike
Time of Update: 2021-08-27
Sales of terminal anti-tumor drugs in physical pharmacies in cities in China (unit: ten thousand yuan) Source: Mi Nei. com, China's urban physical pharmacy terminal competition pattern For newly approved innovative drugs, retail pharmacies are the main battlefield for sales .
-
CDE publicly solicits opinions on the 48th batch of chemical generic drug reference preparation catalogues
Time of Update: 2021-08-27
Medical Network News, August 19 On August 17, CDE's official website issued a notice on the public solicitation of "Chemical Generic Drug Reference Preparation Catalog (48th batch)" . The CDE orga
-
The 6th domestically produced PD-1 will be approved soon
Time of Update: 2021-08-27
FinishingrainbowToday, Sina Pharmaceuticals inquired on the official website of the State Food and Drug Administration and found that the recombinant fully human anti-PD-1 monoclonal antibody developed by Yuheng Pharmaceutical/WuXing Biologics-Sepalizumab injection (GLS-010 injection), used For the treatment of patients with relapsed or refractory classic Hodgkin’s lymphoma (r/r cHL) above the second-line level, it has entered the “under review” status and is expected to be approved by the NMPA in the near future.
-
Zhendong Pharmaceutical sells "China's calcium king" and "hair" economy can become a new business growth pole
Time of Update: 2021-08-27
Chart 2: 2017-2021Q1 Langdi calcium carbonate D3 retail market + grade hospitals(Level two and three) Sales scale (unit: million yuan)Data source: Zhongkang CMH, Zhongkang CHIS Kaisi System, Zhongkang Industrial Capital Research CenterThe interim report shows that in the first half of this year, Langdi's calcium series products maintained a steady growth of 48.
-
Linlu Pharmaceutical Appoints Dr. Feng Luo as Chief Development Officer
Time of Update: 2021-08-27
Feng Luo as the Chief R&D Officer, responsible for the clinical and preclinical/translational medicine department .
In the position of Chief R&D Officer, in addition to leading the establishment of the preclinical and translational medicine department of Linglu, Dr.
-
Novartis® (Scucci Yumab) approved for psoriasis in children and adolescents in China
Time of Update: 2021-08-27
In China, Coshanting® has been approved for the treatment of "adult patients with moderate to severe plaque psoriasis who meet the indications of systemic therapy or phototherapy" and "adult patients with ankylosing spondylitis with poor conventional therapy" Patients", and will be officially included in the National Medical Insurance Directory in 2020 .
-
Focus on monitoring drug sales status and development trends
Time of Update: 2021-08-27
Comparing the key monitoring and rational use catalogs of various provinces shows that all provinces except Inner Mongolia and Tibet have adopted the national version of 20 varieties.
-
CSPC Claudin 18.2 targets ADC to initiate clinical co-targeted monoclonal antibody up to US$640 million to go overseas
Time of Update: 2021-08-27
On August 17, the Insight database showed that the SYSA1801 injection, a class 1 new drug of CSPC Jushi Biologics, started clinical trials for CLDN18.
NovaRock will also use its NovaTE bispecific antibody technology platform to collaborate with Flame Biosciences to discover and pre-clinically develop two new double antibodies.
-
Nine Class 1 new drugs were approved clinically from Tengshengbo Pharmaceutical, Hengrui Pharmaceutical, Qilu Pharmaceutical and other companies
Time of Update: 2021-08-27
Text|Pharmaceutical Mission HillsAccording to the latest announcement by the Center for Drug Evaluation (CDE) of the State Drug Administration of China, a number of Class 1 new drugs have recently obtained implied approval for clinical trials, including IL-17A antibody, PD-1/CTLA-4 bispecific antibody, and ERK kinase inhibitor agents of different mechanism of action, of C5a in development of drug targeting antibody, etc.
-
The annual treatment cost is less than 20,000 yuan. The fifth domestic PD-1 pricing flows out
Time of Update: 2021-08-27
A few days ago, the fifth domestically produced PD-1-Kangfang Biologics and CP Tianqing's Paimrizumab injection (Annico) is priced out: the retail price is 4875 yuan/100mg, combined with the supportin
-
FDA today accelerates approval of GlaxoSmithKline PD-1 antibody to treat specific solid tumors
Time of Update: 2021-08-27
Today, GlaxoSmithKline (GSK) announced that the US FDA has accelerated the approval of the company’s PD-1 antibody Jemperli (dostarlimab-gxly) for extended indications for the treatment of relapsed or advanced stages with mismatch repair defects (dMMR) Patients with solid tumors .
-
The fifth batch of nationally selected drugs started to be listed on the Internet, where should the medical representatives go?
Time of Update: 2021-08-27
AnhuiAnhuiOn July 28, the Anhui Provincial Pharmaceutical Centralized Procurement Service Center issued the "Notice on Declaring the Information of Selected Products Related to the Fifth Batch of National Organizations for Centralized Procurement of Drugs .
-
The collection of proprietary Chinese medicines is here!
Time of Update: 2021-08-27
Regarding the centralized procurement catalogue of Hubei Province, the above-mentioned experts told Cyberlan that whether it is chemical drugs, biological preparations or proprietary Chinese medicines, in order to achieve full competition, save medical insurance funds, and reduce the expected effects of patients’ burdens, they all need to be satisfied.
-
The State Food and Drug Administration released the 44th batch of generic drug reference preparations catalog
Time of Update: 2021-08-27
Medical Network News on August 19 On August 18, the State Food and Drug Administration issued a notice on the list of generic drugs reference preparations (the 44th batch) .
-
Price reduction of a batch of drugs: up to 90%
Time of Update: 2021-08-27
LiaoningOn August 16, the Centralized Procurement Network of Medicines and Medical Consumables in Liaoning Province issued the "Notice on the Results of the Active Price Reduction of 318 Drugs including Cefadroxil Tablets" .
-
More than 770 million people have been vaccinated with the new crown vaccine in my country
Time of Update: 2021-08-26
The National Health Commission: The number of people who completed the entire process of vaccination of my country's new crown vaccine exceeded 770 million people.
-
Anti-coronavirus broad-spectrum monoclonal antibodies can cope with existing mutant strains
Time of Update: 2021-08-26
Anti-coronavirus broad-spectrum monoclonal antibodies can cope with existing mutant strains Anti-New Coronavirus Broad-Spectrum Monoclonal Antibody Can Cope with Existing Variants Science and Technology Daily, Beijing, August 19 (Reporter Lu Chengkuan) The reporter learned from the Institute of Microbiology, Chinese Academy of Sciences on the 19th that researchers from the Institute and other units have developed a blocking type that can target multiple coronavirus invasion receptors, ACE2.
-
Adjuvant targeted therapy after early and mid-stage lung cancer surgery can reduce the risk of recurrence in patients
Time of Update: 2021-08-26
Wu Yilong, the life director of Guangdong Provincial People's Hospital and the honorary director of Guangdong Lung Cancer Research Institute, said recently that the latest study found that adjuvant targeted therapy after early and mid-stage lung cancer surgery can reduce the risk of recurrence and brain metastasis in patients .
-
Xu Jianguo, academician of the Chinese Academy of Engineering: The new coronavirus is natural origin
Time of Update: 2021-08-26
China News Service, Beijing, August 13 (Reporter Huang Yuqin) Xu Jianguo, an academician of the Chinese Academy of Engineering and a medical microbiologist, said at a briefing on the traceability of the new crown virus in China on the 13th that the new crown virus is of natural origin and cannot be manufactured artificially .
-
Breakthrough infection: the new crown delta strain is 3 times that of other strains
Time of Update: 2021-08-26
Another study published in the medRxiv preprint by researchers at the University of Wisconsin-Madison recently proved that the high viral load of the Delta strain is associated with high infectivity .
